Gen-Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$399K Sell
4,355
-1,005
-19% -$87.9K 0.11% 154
2026
Q1
$457K Sell
5,360
-855
-14% -$76.2K 0.14% 139
2025
Q4
$491K Sell
6,215
-2,120
-25% -$166K 0.16% 130
2025
Q3
$666K Sell
8,335
-7,742
-48% -$660K 0.23% 106
2025
Q2
$1.46M Buy
16,077
+1,167
+8% +$107K 0.56% 46
2025
Q1
$1.4M Buy
14,910
+1,298
+10% +$116K 0.58% 43
2024
Q4
$1.24M Buy
13,612
+2,607
+24% +$249K 0.53% 48
2024
Q3
$1.04M Buy
11,005
+1,226
+13% +$125K 0.46% 49
2024
Q2
$949K Buy
9,779
+630
+7% +$58.1K 0.46% 51
2024
Q1
$824K Buy
+9,149
New +$775K 0.41% 52

Other funds holding CL

Gen-Wealth Partners's CL Position: Q2 2026 in Review

Gen-Wealth Partners reduced its Colgate-Palmolive (CL) stake by 19% in Q2 2026, selling an estimated $87.9K and leaving 4,355 shares worth $399K. The position accounts for 0.11% of the portfolio, ranked #154.

Gen-Wealth Partners first reported a position in CL in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.46M in Q2 2025. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Gen-Wealth Partners held 4,355 shares of Colgate-Palmolive worth $399K as of Q2 2026.
  • Gen-Wealth Partners sold 1,005 Colgate-Palmolive shares in Q2 2026, an estimated $87.9K.
  • Colgate-Palmolive made up 0.11% of Gen-Wealth Partners's portfolio in Q2 2026, its #154 holding.
  • Gen-Wealth Partners first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • Gen-Wealth Partners's Colgate-Palmolive position peaked at $1.46M in Q2 2025.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.